# Evaluation of Clinical Parameters on Admission and Medications in Covid-19 Pneumonia (Corona Virus Disease 2019)

> **NCT04379310** · — · COMPLETED · sponsor: **Istanbul Nisantasi University** · enrollment: 54 (actual)

## Conditions studied

- Covid-19

## Interventions

- **DRUG:** ACE Inhibitors and Calcium Channel Blockers

## Key facts

- **NCT ID:** NCT04379310
- **Lead sponsor:** Istanbul Nisantasi University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2020-05-01
- **Primary completion:** 2020-05-05
- **Final completion:** 2020-05-08
- **Target enrollment:** 54 (ACTUAL)
- **Last updated:** 2020-06-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04379310

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04379310, "Evaluation of Clinical Parameters on Admission and Medications in Covid-19 Pneumonia (Corona Virus Disease 2019)". Retrieved via AI Analytics 2026-07-08 from https://api.ai-analytics.org/clinical/NCT04379310. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*